Senti Biosciences Publishes Study on Logic-Gated CAR Designs Enhancing Precision in Cell Therapies

Senti Biosciences has published findings in the scientific journal *Cell Systems* detailing advancements in logic-gated CAR (chimeric antigen receptor) designs for cell therapies. The research outlines a novel approach to engineering immune cells with enhanced precision and control, which could potentially improve the safety and efficacy of treatments targeting complex diseases.

The study focuses on the development of synthetic gene circuits that enable immune cells to respond selectively to specific combinations of signals. By incorporating advanced logic gates into CAR designs, researchers demonstrated how these engineered cells can distinguish between healthy and diseased tissues more effectively. This approach aims to reduce off-target effects while maintaining robust therapeutic activity. The publication highlights experimental results showcasing the functionality of these logic-gated CARs in preclinical models, providing insights into their potential applications across various disease areas.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 1, 2026

Author

GOAI